LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- -
- Market Cap
- -
Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
- Conditions
- Methicillin-resistant Staphylococcus AureusSkin Infection
- Interventions
- Drug: TMP-SMX
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2025-03-10
- Target Recruit Count
- 462
- Registration Number
- NCT03637400
- Locations
- 🇺🇸
Olive View-UCLA Medical Center, Sylmar, California, United States
🇺🇸Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
Inspiratory Muscle Therapy in Subjects With Fontan Circulations
- Conditions
- Single-ventricle
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2024-01-29
- Target Recruit Count
- 7
- Registration Number
- NCT03339466
Bandage Contact Lenses for Corneal Abrasions
- Conditions
- Corneal AbrasionEye Trauma
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2018-02-01
- Target Recruit Count
- 60
- Registration Number
- NCT03206723
- Locations
- 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
Adrenal Cortical Function and Vitamin A Deficiency in Sepsis
- Conditions
- Sepsis
- Interventions
- Drug: Solumedrol 20mgDrug: Vitamin A 100,000 IUOther: Placebo
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2017-05-16
- Target Recruit Count
- 300
- Registration Number
- NCT03152474
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI
- Conditions
- Mucopolysaccharidosis VIMucopolysaccharidosis IMucopolysaccharidosis II
- Interventions
- Drug: Saline Solution for Injection
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2024-10-22
- Target Recruit Count
- 14
- Registration Number
- NCT03153319
- Locations
- 🇺🇸
The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, United States
Hormonal Mechanisms of Sleep Restriction - Axis Study
- Conditions
- Sleep Restriction
- Interventions
- Drug: Placebo oral capsuleDrug: Saline SolutionDrug: Saline Solution for Injection
- First Posted Date
- 2017-05-08
- Last Posted Date
- 2024-04-23
- Target Recruit Count
- 80
- Registration Number
- NCT03142893
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States
Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested Need
- Conditions
- Overactive Bladder
- First Posted Date
- 2017-05-02
- Last Posted Date
- 2017-05-02
- Target Recruit Count
- 70
- Registration Number
- NCT03136601
- Locations
- 🇺🇸
Harbor UCLA Medical Center, Torrance, California, United States
The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2017-03-16
- Last Posted Date
- 2022-02-17
- Target Recruit Count
- 52
- Registration Number
- NCT03081156
- Locations
- 🇺🇸
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States
Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)
- First Posted Date
- 2017-01-04
- Last Posted Date
- 2023-12-13
- Target Recruit Count
- 44
- Registration Number
- NCT03009045
- Locations
- 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸Los Angeles BioMedical Research Institute (LA BioMed), Torrance, California, United States
Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
- First Posted Date
- 2016-10-06
- Last Posted Date
- 2023-02-21
- Target Recruit Count
- 80
- Registration Number
- NCT02926027
- Locations
- 🇺🇸
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), Torrance, California, United States
🇺🇸Intermountain Medical Center, Intermountain Heart Institute, Murray, Utah, United States